{"id":2540,"date":"2025-12-26T11:24:42","date_gmt":"2025-12-26T04:24:42","guid":{"rendered":"https:\/\/naviva.com.vn\/?p=2540"},"modified":"2025-12-26T11:24:42","modified_gmt":"2025-12-26T04:24:42","slug":"hieu-qua-cua-vac-xin-barycela-va-dieu-can-thiet-cua-lieu-tiem-thu-hai","status":"publish","type":"post","link":"https:\/\/tbyt.devjournal.io.vn\/index.php\/hieu-qua-cua-vac-xin-barycela-va-dieu-can-thiet-cua-lieu-tiem-thu-hai\/","title":{"rendered":"Hi\u1ec7u qu\u1ea3 c\u1ee7a v\u1eafc xin Barycela v\u00e0 \u0111i\u1ec1u c\u1ea7n thi\u1ebft c\u1ee7a li\u1ec1u ti\u00eam th\u1ee9 hai"},"content":{"rendered":"

T\u1eeb c\u00e1c h\u01b0\u1edbng d\u1eabn c\u1ee7a WHO cho th\u1ea5y, vi\u1ec7c s\u1eed d\u1ee5ng\u00a0v\u1eafc xin Barycela<\/a>\u00a0trong c\u00e1c l\u1ecbch ti\u00eam 1 ho\u1eb7c 2 li\u1ec1u cho tr\u1ebb em l\u00e0 ho\u00e0n to\u00e0n ph\u00f9 h\u1ee3p.<\/strong><\/span><\/p>\n

\"\"<\/a><\/p>\n

S\u1eed d\u1ee5ng v\u1eafc xin Barycela trong c\u00e1c l\u1ecbch ti\u00eam 1 ho\u1eb7c 2 li\u1ec1u cho tr\u1ebb em l\u00e0 ho\u00e0n to\u00e0n ph\u00f9 h\u1ee3p. \u1ea2nh: NAVIVA GROUP<\/span><\/p>\n

Trong h\u01b0\u1edbng d\u1eabn m\u1edbi nh\u1ea5t v\u1ec1 ti\u00eam ph\u00f2ng v\u1eafc xin th\u1ee7y \u0111\u1eadu c\u1ee7a T\u1ed5 ch\u1ee9c Y t\u1ebf th\u1ebf gi\u1edbi (WHO) \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 th\u00e1ng 11\/2025 \u0111\u00e3 khuy\u1ebfn c\u00e1o l\u1ecbch ti\u00eam 2 li\u1ec1u \u0111\u1ec3 \u0111\u1ea1t hi\u1ec7u qu\u1ea3 b\u1ea3o v\u1ec7 t\u1ed1i \u01b0u \u0111\u1ed1i v\u1edbi b\u1ec7nh th\u1ee7y \u0111\u1eadu.<\/span><\/p>\n

K\u1ebft qu\u1ea3 t\u1eeb c\u00e1c nghi\u00ean c\u1ee9u \u0111\u01b0\u1ee3c vi\u1ec7n d\u1eabn \u0111\u1ec3 l\u00e0m b\u1eb1ng ch\u1ee9ng cho khuy\u1ebfn c\u00e1o n\u00e0y \u0111\u00e3 cho th\u1ea5y hi\u1ec7u qu\u1ea3 t\u0103ng cao r\u00f5 r\u1ec7t c\u1ee7a l\u1ecbch ti\u00eam 2 li\u1ec1u v\u1eafc xin so v\u1edbi ch\u1ec9 1 li\u1ec1u v\u1eafc xin.<\/span><\/p>\n

N\u1ebfu ch\u1ec9 v\u1edbi m\u1ed9t li\u1ec1u ti\u00eam, hi\u1ec7u qu\u1ea3 c\u1ee7a v\u1eafc xin th\u1ee7y \u0111\u1eadu \u0111\u1ea1t \u0111\u1ebfn 95% [1], c\u00f2n v\u1edbi l\u1ecbch ti\u00eam 2 li\u1ec1u, hi\u1ec7u qu\u1ea3 c\u1ee7a v\u1eafc xin th\u1ee7y \u0111\u1eadu \u0111\u1ea1t \u0111\u1ebfn 100% [2].<\/span><\/p>\n

Trong t\u00e0i li\u1ec7u n\u00e0y, WHO c\u0169ng n\u00eau r\u00f5 c\u00e1c qu\u1ed1c gia hi\u1ec7n \u0111ang s\u1eed d\u1ee5ng l\u1ecbch ti\u00eam v\u1eafc xin th\u1ee7y \u0111\u1eadu 1 li\u1ec1u n\u00ean l\u01b0u \u00fd ch\u01b0\u01a1ng tr\u00ecnh ti\u00eam ch\u1ee7ng n\u00e0y ch\u1ec9 \u0111\u1ee7 \u0111\u1ec3 l\u00e0m gi\u1ea3m t\u1ec9 l\u1ec7 t\u1eed vong v\u00e0 t\u1ec9 l\u1ec7 m\u1eafc b\u1ec7nh n\u1eb7ng \u0111\u1ed1i v\u1edbi b\u1ec7nh th\u1ee7y \u0111\u1eadu.<\/span><\/p>\n

L\u1ecbch ti\u00eam 1 li\u1ec1u \u00edt c\u00f3 hi\u1ec7u qu\u1ea3 trong ph\u00f2ng ng\u1eeba virus l\u01b0u h\u00e0nh v\u00e0 kh\u1ea3 n\u0103ng g\u00e2y d\u1ecbch th\u1ee7y \u0111\u1eadu. Li\u1ec1u ti\u00eam th\u1ee9 hai c\u1ea7n \u0111\u01b0\u1ee3c ti\u00eam v\u1edbi kho\u1ea3ng c\u00e1ch \u00edt nh\u1ea5t l\u00e0 4 tu\u1ea7n sau li\u1ec1u ti\u00eam \u0111\u1ea7u ti\u00ean. Tr\u1ebb l\u1edbn v\u00e0 ng\u01b0\u1eddi l\u1edbn c\u1ea7n \u0111\u01b0\u1ee3c ti\u00eam nh\u1eafc li\u1ec1u th\u1ee9 hai n\u00e0y \u0111\u1ec3 c\u00f3 \u0111\u01b0\u1ee3c mi\u1ec5n d\u1ecbch t\u1ed1i \u01b0u.<\/span><\/p>\n

H\u01b0\u1edbng d\u1eabn c\u1eadp nh\u1eadt v\u1ec1 v\u1eafc xin th\u1ee7y \u0111\u1eadu n\u00e0y c\u1ee7a WHO c\u0169ng \u0111\u00e3 x\u00e1c nh\u1eadn c\u00e1c k\u1ebft qu\u1ea3 v\u1ec1 t\u00ednh an to\u00e0n v\u00e0 t\u00ednh sinh mi\u1ec5n d\u1ecbch c\u1ee7a v\u1eafc xin th\u1ee7y \u0111\u1eadu ch\u1ee7ng MAV\/06 – v\u1eafc xin Barycela l\u00e0 t\u01b0\u01a1ng \u0111\u01b0\u01a1ng v\u1edbi c\u00e1c v\u1eafc xin th\u1ee7y \u0111\u1eadu ch\u1ee7ng Oka th\u01b0\u1eddng d\u00f9ng trong c\u00e1c v\u1eafc xin th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n nay [3,4].<\/span><\/p>\n

V\u1eafc xin Barycela \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng nhi\u1ec1u n\u0103m trong Ch\u01b0\u01a1ng tr\u00ecnh ti\u00eam ch\u1ee7ng qu\u1ed1c gia c\u1ee7a H\u00e0n Qu\u1ed1c v\u00e0 nhi\u1ec1u n\u01b0\u1edbc kh\u00e1c c\u0169ng \u0111\u00e3 cho th\u1ea5y hi\u1ec7u qu\u1ea3 l\u00e0m gi\u1ea3m r\u00f5 r\u1ec7t t\u1ec9 l\u1ec7 m\u1eafc b\u1ec7nh th\u1ee7y \u0111\u1eadu th\u1eadm ch\u00ed c\u1ea3 m\u1eafc Zona (Herpes zoster) \u1edf c\u00e1c tr\u1ebb \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc xin [5].<\/span><\/p>\n

C\u00f4ng b\u1ed1 c\u1ee7a WHO c\u0169ng n\u00eau r\u00f5 vi\u1ec7c chuy\u1ec3n \u0111\u1ed5i v\u1eafc xin th\u1ee7y \u0111\u1eadu s\u1ed1ng gi\u1ea3m \u0111\u1ed9c l\u1ef1c gi\u1eefa ch\u1ee7ng Oka v\u00e0 ch\u1ee7ng MAV\/06 l\u00e0 an to\u00e0n, kh\u00f4ng c\u00f3 c\u00e1c ph\u1ea3n \u1ee9ng b\u1ea5t l\u1ee3i x\u1ea3y ra \u1edf tr\u1ebb kho\u1ebb m\u1ea1nh \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc xin [6].<\/span><\/p>\n

\"\"<\/a><\/p>\n

V\u1eafc xin th\u1ee7y \u0111\u1eadu Barycela do GC Biopharma (H\u00e0n Qu\u1ed1c) s\u1ea3n xu\u1ea5t \u1ea2nh: NAVIVA GROUP<\/span><\/p>\n

T\u1eeb c\u00e1c khuy\u1ebfn c\u00e1o tr\u00ean cho th\u1ea5y vi\u1ec7c s\u1eed d\u1ee5ng v\u1eafc xin th\u1ee7y \u0111\u1eadu ch\u1ee7ng MAV\/06 – v\u1eafc xin Barycela trong c\u00e1c l\u1ecbch ti\u00eam 1 ho\u1eb7c 2 li\u1ec1u cho tr\u1ebb em l\u00e0 ho\u00e0n to\u00e0n ph\u00f9 h\u1ee3p.<\/span><\/p>\n

V\u1eafc xin th\u1ee7y \u0111\u1eadu Barycela c\u00f3 ch\u1ee9a ch\u1ee7ng MAV\/06 do GC Biopharma s\u1ea3n xu\u1ea5t v\u00e0 hi\u1ec7n \u0111ang \u0111\u01b0\u1ee3c NAVIVA GROUP ph\u00e2n ph\u1ed1i t\u1ea1i Vi\u1ec7t Nam.<\/span><\/p>\n

1. Bayer O et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine. 2007;25(37\u201338):6655\u201360.<\/span><\/p>\n

2. Hong K et al. Effectiveness of two-dose varicella vaccination: Bayesian network meta-analysis. Pediatr Infect Vaccine. 2024;31(1):55\u201363.<\/span><\/p>\n

3. Kim SH et al. Seroprevalence rate after 1 dose of varicella vaccine in infants. J Infect. 2010;61(1):66\u201372.<\/span><\/p>\n

4. Choi UY et al. Immunogenicity and safety profiles of a new MAV\/06 strain varicella vaccine in healthy children: a multinational, multicenter, randomized, double blinded, active-controlled phase III study. Vaccine. 2021;39(12):1758\u201364<\/span><\/p>\n

5. Choi J-K et al. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003\u20132015. Hum Vaccin Immunother. 2019;15(11):2554\u201360.<\/span><\/p>\n

6. Kang HM et al. Safety of interchanging the live attenuated MAV\/06 strain and OKA strain varicella vaccines in children. Vaccines (Basel). 2023;11(9):1442.<\/span><\/p>\n

\n

B\u1ea3n h\u01b0\u1edbng d\u1eabn c\u1eadp nh\u1eadt v\u1ec1 v\u1eafc xin th\u1ee7y \u0111\u1eadu c\u1ee7a WHO \u0111\u00e3 n\u00eau r\u00f5:<\/span><\/p>\n

– C\u1ea7n thi\u1ebft ph\u1ea3i ti\u00eam v\u1eafc xin th\u1ee7y \u0111\u1eadu theo l\u1ecbch ti\u00eam 2 li\u1ec1u v\u1eafc xin c\u00e1ch nhau \u00edt nh\u1ea5t 4 tu\u1ea7n \u0111\u1ec3 c\u00f3 \u0111\u01b0\u1ee3c hi\u1ec7u qu\u1ea3 b\u1ea3o v\u1ec7 t\u1ed1i \u01b0u.<\/span><\/p>\n

– V\u1eafc xin th\u1ee7y \u0111\u1eadu ch\u1ee7ng MAV\/06 – v\u1eafc xin Barycela c\u00f3 t\u00ednh an to\u00e0n v\u00e0 t\u00ednh sinh mi\u1ec5n d\u1ecbch t\u01b0\u01a1ng \u0111\u01b0\u01a1ng v\u1edbi c\u00e1c v\u1eafc xin th\u1ee7y \u0111\u1eadu ch\u1ee7ng Oka th\u01b0\u1eddng d\u00f9ng trong c\u00e1c v\u1eafc xin th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n nay.<\/span><\/p>\n

– Ho\u00e1n \u0111\u1ed5i v\u1eafc xin th\u1ee7y \u0111\u1eadu s\u1ed1ng gi\u1ea3m \u0111\u1ed9c l\u1ef1c gi\u1eefa ch\u1ee7ng Oka v\u00e0 ch\u1ee7ng MAV\/06 l\u00e0 an to\u00e0n, kh\u00f4ng c\u00f3 c\u00e1c ph\u1ea3n \u1ee9ng b\u1ea5t l\u1ee3i x\u1ea3y ra \u1edf tr\u1ebb kh\u1ecfe m\u1ea1nh \u0111\u01b0\u1ee3c ti\u00eam v\u1eafc xin.<\/span><\/p>\n<\/div>\n

Ngu\u1ed3n: B\u00e1o lao \u0111\u1ed9ng<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

T\u1eeb c\u00e1c h\u01b0\u1edbng d\u1eabn c\u1ee7a WHO cho th\u1ea5y, vi\u1ec7c s\u1eed d\u1ee5ng\u00a0v\u1eafc xin Barycela\u00a0trong c\u00e1c l\u1ecbch ti\u00eam 1 ho\u1eb7c 2 li\u1ec1u cho tr\u1ebb em l\u00e0 ho\u00e0n to\u00e0n ph\u00f9 h\u1ee3p. S\u1eed d\u1ee5ng v\u1eafc xin Barycela trong c\u00e1c l\u1ecbch ti\u00eam 1 ho\u1eb7c 2 li\u1ec1u cho tr\u1ebb em l\u00e0 ho\u00e0n to\u00e0n ph\u00f9 h\u1ee3p. \u1ea2nh: NAVIVA GROUP Trong h\u01b0\u1edbng d\u1eabn […]<\/p>\n","protected":false},"author":3,"featured_media":2541,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[],"class_list":["post-2540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tin-tuc"],"acf":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/posts\/2540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/comments?post=2540"}],"version-history":[{"count":0,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/posts\/2540\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/media?parent=2540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/categories?post=2540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tbyt.devjournal.io.vn\/index.php\/wp-json\/wp\/v2\/tags?post=2540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}